首页> 外国专利> IMPROVED COMBINATION BACTERIOLYTIC THERAPY FOR THE TREATMENT OF TUMORS

IMPROVED COMBINATION BACTERIOLYTIC THERAPY FOR THE TREATMENT OF TUMORS

机译:改良的组合细菌疗法治疗肿瘤

摘要

Current approaches for treating cancer are limited, in part, by the inability of drugs to affect the poorly vascularized regions of tumors. We have found that spores of anaerobic bacteria in combination with agents which interact with microtubules can cause the destruction of both the vascular and avascular compartments of tumors. Two classes of microtubule inhibitors were found to exert markedly different effects. Some agents that inhibited microtubule synthesis, such as vinorelbine, caused rapid, massive hemorrhagic necrosis when used in combination with spores. In contrast, agents that stabilized microtubules, such as the taxane docetaxel, resulted in slow tumor regressions that killed most neoplastic cells. Remaining cells in the poorly perfused regions of tumors could be eradicated by sponzlated bacteria. Mechanistic studies showed that the microtubule destabilizers, but not the microtubule stabilizers, radically reduced blood flow to tumors, thereby enlarging the hypoxic niche in which spores could germinate. A single intravenous injection of spores plus selected microtubule-interacting agents was able to cause regressions of several tumors in the absence of excessive toxicity.
机译:当前用于治疗癌症的方法在一定程度上受到药物无法影响肿瘤血管较弱的区域的限制。我们已经发现,厌氧细菌的孢子与与微管相互作用的试剂结合可以破坏肿瘤的血管和无血管腔室。发现两类微管抑制剂发挥明显不同的作用。当与孢子结合使用时,某些抑制微管合成的药物(如长春瑞滨)会导致快速,大量的出血性坏死。相比之下,紫杉烷多西紫杉醇等稳定微管的药物可导致缓慢的肿瘤消退,从而杀死大多数肿瘤细胞。肿瘤灌注不足的区域中的剩余细胞可以被自发化细菌根除。机理研究表明,微管去稳定剂而不是微管稳定剂从根本上减少了流向肿瘤的血液,从而扩大了低氧环境,孢子可能在其中发芽。在没有过度毒性的情况下,单次静脉内注射孢子加选定的微管相互作用剂能够导致几种肿瘤消退。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号